AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. CellSource Co.,Ltd.
  3. Financials
  4. Net income margin (%)

CellSource Co.,Ltd.【JP:4880】

Market cap
¥7.5B
P/E ratio
-54.8x
CellSource processes blood and fat tissue into therapeutic substances for medical institutions offering regenerative medicine treatments like knee osteoarthritis and infertility care.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Oct 31, 20250.3-94.74%
Oct 31, 20245.5-73.30%
Oct 31, 202320.5-14.06%
Oct 31, 202223.8+6.84%
Oct 31, 202122.3+50.91%
Oct 31, 202014.8+19.26%
Oct 31, 201912.4-22.33%
Oct 31, 201815.9-25.69%
Oct 31, 201721.5+364.40%
Oct 31, 20164.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)